Mark J. Enyedy - Jun 11, 2021 Form 4 Insider Report for LogicBio Therapeutics, Inc. (LOGC)

Role
Director
Signature
/s/ Jonathan Quick, as Attorney-in-Fact
Stock symbol
LOGC
Transactions as of
Jun 11, 2021
Transactions value $
$0
Form type
4
Date filed
6/14/2021, 08:01 PM
Next filing
Jul 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LOGC Stock Option (right to buy) Award $0 +12.5K $0.00 12.5K Jun 11, 2021 Common Stock 12.5K $4.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan as provided under the Company's compensation policy for non-employee directors. All of the options will vest and become exercisable on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer through the vesting date.